Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-3.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Return on Invested Capital [ROIC] (2024)

Updated

Mereo BioPharma (MREO) posted Return on Invested Capital [ROIC] of -467.10% for Q3 2024, down 408.56 percentage points from the prior quarter.

Analysis

Mereo BioPharma (MREO) Return on Invested Capital [ROIC] (2024) Analysis & Trends

For FY2023, Mereo BioPharma's Return on Invested Capital [ROIC] came in at -41.02%, up 3.93 percentage points from FY2022.

  • Annual Return on Invested Capital [ROIC] shows a five-year change of +1.23 percentage points (FY2018 to FY2023).
  • In prior years, Mereo BioPharma's Return on Invested Capital [ROIC] was -44.95% in FY2022 (-8.81 pp), -36.14% in FY2021 (+86.27 pp), -122.41% in FY2020 (-64.21 pp) and -58.20% in FY2019 (-15.96 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Mereo BioPharma 44.71 Mn -105.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -467.10%
Jun 30, 2024 -58.54%
Mar 31, 2024 -53.82%
API Access

Mereo BioPharma Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=MREO&period=max&api_key=YOUR_API_KEY